Investors & Media
What’s new.
Press releases
Press releases.
April 29th 2024
Immutep Quarterly Activities Report Q3 FY24
Investor updates
Analyst reports
Analyst reports.
May 3rd 2024
Bell Potter - More Great Data, Major Catalyst Nears; Maintain Buy, A$0.80 Valuation (Analyst: Thomas Wakim)
May 2nd 2024
Canaccord Genuity - Ticking all the boxes - initial positive read from efti in soft tissue sarcoma; Rated Buy, A$1 Price Target ( Analyst: Elyse Shapiro)
April 30th 2024